- Foreign media: LINK demand may be supported by the new mechanism
- Spot silver has just surpassed the $65.00/oz mark and is now quoted at $65.01/oz, up 0.88% on the day; the main COMEX silver futures contract is now quoted at $65.20/oz, up 0.33% on the day.
- After the data release, spot gold quickly rose by $12 to $4,381 (0.70%), having already increased by $15 in advance of the data release.
- The US Dollar Index dropped about 8 points in the short term, hitting a low of 99.51.
- Vistagen Therapeutics: Current Resources Not Sufficient to Extend Cash Runway for More Than a Year >VTGN
- The U.S. Treasury yield curve steepens further, mortgage spreads strengthen against the trend, and geopolitical remarks together with retail data stir up Friday's close
- Spot gold has just surpassed the $4,380.00/oz mark, now trading at $4,380.02/oz, up 0.67% on the day; the main COMEX gold futures contract is currently at $4,435.80/oz, up 0.35% on the day.
- Cycurion Sees Improved Operating Performance in 2nd Half of 2026, Into 2027 >CYCU
- Zeo Energy 2Q Loss/Shr 7c >ZEO
- Zeo Energy 2Q Rev $16.2M >ZEO
- Cycurion 2Q Loss/Shr 41c >CYCU
- Cycurion 2Q Rev $3.76M >CYCU
- Data Storage 2Q Sales $358,530 >DTST
- Moleculin Biotech 2Q Research and Development Expenses $5.5M >MBRX
- Moleculin Biotech 2Q Loss/Shr $1.40 >MBRX
- Clene 2Q Loss $13.4M >CLNN
- Clene 2Q Loss/Shr $1.08 >CLNN
- Proficient Auto Logistics Completes Acquisition Of Hansen & Adkins >PAL
- Star Equity Holdings Enters Into Merger Agreement To Acquire Harte Hanks >STRR
- Data Storage 2Q Loss/Shr 55c >DTST
- Tomi Environmental 2Q Sales $2.25M >TOMZ
- Shale oil giants tighten their wallets, high oil price dividends return to shareholders, and US crude oil supply growth quietly loses momentum
- Australian Dollar regains momentum as hawkish RBA meets softer US inflation
- U.S. Department of Defense: Agreements reached with Boeing and Raytheon. The agreements aim to enhance missile components production.
- U.S. Department of Defense: Agreement reached with Boeing and Raytheon to strengthen production of critical SM-3 Block IIA and SM-3 Block IB munitions.
- Spot platinum has just broken through the $1,740.00 per ounce mark, now trading at $1,740.05 per ounce, up 1.17% on the day; the main Nymex platinum futures contract is now quoted at $1,748.0 per ounce, up 0.91% on the day.
- Swedish Krona: Undervalued SEK with constrained upside – Nordea
- Nasdaq-Listed Giant’s Ethereum Adventure Lasted Only One Year! All ETH Sold, Investment to Be Made in This Area!
- US Stock Market Preview | Major Index Futures Mixed; US July Retail Sales Data Coming Tonight; SanDisk (SNDK.US) Up Over 6% Pre-market
- Wall Street welcomes the "intervention bonus": Every time the Japanese government intervenes to rescue the market, it creates a perfect shorting window for yen bears.
- The U.S. Department of Defense has reached an agreement with Boeing and Raytheon.
- Spot gold has just broken through the $4,370.00 per ounce mark, now quoted at $4,370.67 per ounce, up 0.45% for the day; main COMEX gold futures are now quoted at $4,426.30 per ounce, up 0.13% for the day.
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- India’s Crypto Market Could Hit $14.2B by 2034: What’s Driving Growth Despite Taxes and Regulation?
- Scienture Holdings 2Q Loss/Shr 7c >SCNX
- US Dollar: Mixed data and higher yields shape outlook – Danske Bank
- The surge in bulk commodities hides risks, AI’s aura fades—how long can this commodity bull market last?
- The yen retraces half of its intervention-driven gains on the weekly chart as the crucial 160 level approaches; a September rate hike may be the last line of defense.
- PMV Pharmaceuticals 2Q Research and Development Expenses $14.7M
- Annovis Bio 2Q Loss $14.8M >ANVS
- Annovis Bio 2Q Loss/Shr 40c >ANVS
- GT Biopharma 2Q Research and Development Expenses About $1.1M >GTBP
- Quince Therapeutics: Runway to Fund Operations Through End 2028 >QNCX
- VerifyMe 2Q Loss/Shr 4c >VRME
- Quince Therapeutics 2Q Loss/Shr $12.31 >QNCX
- Suncrete 2Q Loss/Shr 72c >RMIX
- Replimune Group: Tudriqev in Combination With Nivolumab Will Launch Within 60 Days >REPL
- Suncrete 2Q Rev $97.2M >RMIX
- Allarity Therapeutics 2Q Research and Development Expenses $1.3M >ALLR
- SK Hynix’s performance surges in the first half of the year, with employee compensation and R&D investment soaring simultaneously
- Allarity Therapeutics 2Q Loss/Shr 21c >ALLR
- Computer Modelling Announces Commencement of Previously Announced Substantial Issuer Bid >CMG.T
- Swiss Franc: Strong growth may curb losses against Euro – Rabobank
- PMV Pharmaceuticals 2Q Loss/Shr 34c >PMVP
- PMV Pharmaceuticals 2Q Loss $18.1M >PMVP
- Replimune Group 1Q Loss/Shr 72c >REPL
- Replimune Group 1Q Loss $69.8M >REPL
- Conifex Timber 2Q Rev $23M >CFF.T
- Galectin Therapeutics 2Q Loss/Shr 14c >GALT
- Galectin Therapeutics 2Q Research and Development Expenses $2.1M >GALT
- Venice Token is Predicted to Drop to $ 9.43 By Aug 18, 2026
- Bitcoin trades near 50-day SMA, eyes $65,400 breakout or risk $62,200 liquidity sweep
- RedotPay delays US IPO plans amid regulatory hurdles
- Swiss Franc edges up from lows against the US Dollar with US Retail Sales on tap
- Regulatory filings disclosed on Friday show that in the first half of 2026, Samsung Electronics’ R&D investment hit a record high of 27.3 trillion won (equivalent to $19 billion). The Korean tech giant’s R&D expenditure for January to June rose 51.5% year-on-year from 18.06 trillion won, setting a new half-year historical record. Samsung Electronics also set a new half-year record for equipment investment in the first half of the year, reaching 28 trillion won, an increase of nearly 5 trillion
- Foreign media: SOL consolidation with decreasing volume is approaching a decisive move
- Correct: LanzaTech Global Sees 2026 Adjusted Ebitda Negative $22M-$26M >LNZA
- LanzaTech Global 2026 Adjusted Ebitda Negative $22M-$26M >LNZA
- TuHURA Biosciences: Expect to Initiate Phase 1b/2 Trial of VISTA in mutNPM1 R/r AML in 2H 2026 >HURA
- LanzaTech Global Sees 2026 Rev $50M-$55M >LNZA
- TuHURA Biosciences: Expect to Receive Orphan Drug Designation in MCC in 2H 2026 >HURA
- LanzaTech Global Sees 3Q Rev $8M-$11M >LNZA
- TuHURA Biosciences Expect Preliminary Results From IR Study IFX-2.0 With Keytruda for Deep Seated MCC in 1H2027 >HURA
- "Ocado, the 'Tesla of Groceries', sees a dramatic 45% rebound in stock price! New warehouse in South Korea ignites valuation recovery; Ocado enters a critical inflection point for 'distress reversal'"
- LanzaTech Global 2Q Adjusted Ebitda Negative $7.6M >LNZA
- TuHURA Biosciences: Cash and Cash Equivalents of $1M at June 30 >HURA
- LanzaTech Global 2Q Net Boosted by Non-Cash Unrealized Gain on Investment in SGLT >LNZA
- LanzaTech Global 2Q Net $184.3M >LNZA
- SurgePays 2Q Rev $16.2M >SURG
- South African Rand: ZAR outperforms on carry and Gold – Societe Generale
- Spot gold has just surpassed the $4,360.00/oz mark, now quoted at $4,360.34/oz, up 0.22% for the day; COMEX gold futures main contract is now quoted at $4,416.80/oz, down 0.08% for the day.
- Bank of England to Test Interoperability Between Stablecoins and the Digital Pound
- Cable One Names Heather McCallion Chief Operating Officer
- 992.5 Million XRP Now Locked, But Ripple Is Not Behind It
- Solana Set for Major Finality Upgrade
- Shytoshi Kusama's Litecoin Connection? SHIB Veteran Gives Take
- Lantern Pharma 2Q Research and Development Expenses About $1.8M >LTRN
- Lantern Pharma 2Q Loss/Shr 57c >LTRN
- IQSTEL Sees 6-Mos Rev $207M >IQST
- Beneficient 1Q Rev $12.2M >BENF
- Beneficient 1Q Loss/Shr 47c >BENF
- Milestone Scientific 2Q Loss $1.06M >MLSS
- Edible Garden AG 2Q Loss/Shr $18.79 >EDBL
- MCX launches crude sunflower oil futures contract
- A Weak Rupee Does Not Automatically Mean Bitcoin Will Rise in India
- Canadian Dollar: Manufacturing sales drag from energy – TD Securities
- Bitcoin Enters Historic Capitulation Zone
